Synapsoft logo
AI Insights from Disclosures
Searching...
iNtRON Biotechnology, Inc. 048530
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
iNtRON Biotechnology, Inc.'s business is broadly divided into two areas. The first is the New Drug part (Bio-New Drug / Biomedicine development business), in which the company develops various bio-new drugs based on bacteriophage-based technology and bacteriophage-derived Endolysin-based technology, utilizing bacteriophages, which play a role in balancing and controlling bacteria.
Representative Director 윤성준, 윤경원(각자대표)
Founded January 18, 1999
Corporation Type KOSDAQ
Industry Classification Manufacture of medicinal chemicals
Corporate number 11011-1636004
Business number 215-81-74710
Phone Number 031-739-5678
Fax Number 031-739-5353
Company Address 137 Sagimakgol-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant